Intra-articulaar treatment with Hylan G-F 20 under ultrasound guidance in hip osteoarthritis. Clinical results after 12 months follow-up;Terapia intra-articolare con acido ialuronico (Hylan G-F 20) sotto guida ecografica nell'artrosi dell'anca. Risultati clinici a 12 mesi

Reumatismo

Volumn 57, Issue 1, 2005, Pages 36-43

  Migliore, Alberto ^a   Tormenta, S ^a   Valente, C ^a   Massafra, U ^a   Martin, L S Martin ^b   Carmenini, E ^c   Bernardini, A ^a   Alimonti, A ^a  

^a FATEBENEFRATELLI HOSPITAL   (Italy)

^b REGINA APOSTOLORUM HOSPITAL   (Italy)

^c Dipartimento di Medicina Interna   (Italy)

Author keywords

Hip osteoarthritis; Hylan GF 20; US guided intra articulaar injection; Viscosupplementation

Indexed keywords

HYALURONIC ACID; HYLAN G F 20; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; ECHOGRAPHY; FEMALE; FOLLOW UP; HIP OSTEOARTHRITIS; HUMAN; MALE; PAIN ASSESSMENT; VISCOSITY; VISUAL ANALOG SCALE;

AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYALURONIC ACID; INJECTIONS, INTRA-ARTICULAR; INJECTIONS, INTRALESIONAL; MALE; MIDDLE AGED; OSTEOARTHRITIS, HIP; PILOT PROJECTS; PROSPECTIVE STUDIES;

EID: 15944394072     PISSN: 00487449     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Balazs EA, Denlinger JL. Viscosupplementation: a new concept in the treatment of osteoarthritis. J Rheumatol Suppl 1993; 39: 3-9.
2. Altman RD, Hochberg MC, Moskowitz RW, Schnitzer TJ. Recommendations for the Medical Management of Osteoarthritis of the Hip and Knee. Arthritis Rheum 2000; 43: 1905-15.
3. Espallargues M, Pons JM. Efficacy and safety of viscosupplementation with Hylan G-F 20 for the treatment of knee osteoarthritis: a systematic review. Int J Technol Assess Health Care; 2003; 19: 41-56.
4. Raynauld JP, Torrance GW, Band PA, Goldsmith CH, Tugwell P, Walker V, et al. A prospective, randomized, pragmatic health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 1 of 2): clinical results. Osteoarthritis Cartilage 2002; 10: 506-17.
5. Adams ME, Atkinson MH, Lussier A, Schulz JI, Siminovitch KA, Wade JP, et al. The role of viscosupplementation with hylan G-F 20 (Synvisc) in the treatment of osteoarthritis of the knee: a Canadian multicenter trial comparing hylan G-F alone, hylan G-F 20 with nonsteroidal anti-inflammatory drugs (NSAIDs) and NSAIDs alone. Osteoarthritis Cartilage 1995; 3: 213-25.
6. Tamir E, Robinson D, Koren R, Agar G. Intra-articular hyaluronan for the treatment of osteoarthritis of the knee: A randomised, double blind, placebo controlled study. Clin Exp Rheumatol 2001; 19: 265-70.
7. Kolarz G, Kotz R, Hochmayer I. Long-term benefits and repeated treatment cycles of intra-articular sodium hyaluronate (Hyalgan) in patients with osteoarthritis of the knee. Semin Arthritis Rheum 2003; 32: 310-9.
8. Wobig M, Dickhut A, Maier R, Vetter G. Viscosupplementation with hylan G-F 20: a 26 week controlled trial of efficacy and safety in the osteoarthritis knee. Clin Ther 1998; 20: 410-23.
9. Dickson DJ, Hosie G, English JR. A double-blind, placebo-controlled comparison of hylan G-F 20 against diclofenac in knee osteoarthritis. J Clin Res 2001; 4: 41-52.
10. Brocq O, Tran G, Breuil U, Grisot C, Flory P, Euller-Zuegler L. Hip osteoarthritis: short term efficacy and safety of viscosupplementation by hylan G-F 20. an open-label study in 22 patients. Joint Bone Spine 2002; 69: 388-91.
11. Migliore A, Martin LSM, Alimonti A, Valente C, Tormenta S. Efficacy and safety of viscosupplementation by ultrasound-guided intra-articular injection in osteoarthritis of the hip. Osteoarthritis Cartilage 2003; 11: 305-6.
12. Conrozier T, Bertin P, Mathieu P, Chariot J, Bailleul F, Treves R, et al. Intra-articular injections of hylan G-F 20 in patients with symptomatic hip osteoarthritis: an open label, multicentre, pilot study. Clin Exp Rheumatol 2003; 21: 605-10.
13. Bragantini A, Molinaroli F. A pilot clinical evaluation of the treatment of hip osteoarthritis with hyaluronic acid. Curr Ther Res Clin Exp 1994; 55: 319-30.
14. Leopold SS, Battista V, Oliverio JA. Safety and efficacy of intraarticular hip injection using anatomic landmarks. Clin Orthop 2001; 391: 192-7.
15. Jackson DW, Evans NA, Thomas BM. Accuracy of needle placement into the intra-articular space of the knee. J Bone Joint Surg Am 2002; 84A: 1522-7.
16. Qvistgaard E, Kristoffersen H, Terslev L, Danneskiold-Samsoe B, Torp-pedersen S, Bliddal H. Guidance by ultrasound of intra-articular injections in the knee and hip joints. Osteoarthritis Cartilage 2001; 9: 512-7.
17. Altman R, Alarcon G, Appelrouth D, Bloch D, Borenstein D, Brandt K, et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum 1991; 34: 505-14.
18. Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis 1957; 16: 494-502.
19. Lequesne MG. The Algofunctional Indices for Hip and Knee Osteoarthritis. J Rheumatology 1997; 24, 4: 779-81.
20. Sturkenboom MC, Romano F, Simon G, Correa-Leite ML, Villa M, Nicolosi Á, et al. The iatrogenic costs of NSAID therapy: a population study. Arthritis Rheum 2002; 47: 132-40.
21. Henry D. Non-steroidal anti-inflammatory drugs and the risk of development of congestive cardiac failure and functional renal impairment. Proceedings of the international conference on inflammopharmacology. 1997. San Francisco.
22. Page J, Henry D. Consumption of NSAIDs and development of congestive heart failure in elderly patients: an underrecognized public health problem. Arch Intern Med 2000; 160: 777-84.
23. Lussier A, Cividino AA, McFarlane CA, Olszynski WP, Potashner WJ, de Medicis R. Viscosupplementation with Hylan for the Treatment of Osteoarthritis: Findings from Clinical Practice in Canada. J Rheumatology 1996; 23: 1579-85.
24. Marshall KW. The current status of hylan therapy for the treatment of osteoarthritis. Today's Ther Trends 1997; 15: 99-108.
25. Altman RD. Status of hyaluronan supplementation therapy in osteoarthritis. Curr Rheumatol Rep 2003: 5: 7-14.
26. Migliore A, Martin Martin LS, Valente C, Alimonti A, Bernardini A, Monno D, et al. Intra-articular treatment with Hylan G-F 20 (Synvisc) reduces NSAIDS consumption in patients with symptomatic osteoarthritis of the hip: preliminary clinical observations. Osteoporosis International 2002; 13: S20.
27. Ayral X. Injections in the treatment of osteoarthritis. Best Pract Res Clin Rheumatol 2001; 15: 609-26.